Hospital Pharmacy presents this feature to keep pharmacists abreast of new publications in the medical/pharmacy literature. Articles of interest will be abstracted monthly regarding a broad scope of topics. Suggestions or comments may be addressed to: Jacyntha Sterling, Drug Information Specialist at Saint Francis Hospital, 6161 S Yale Ave., Tulsa, OK 74136 or e-mail: jasterling@saintfrancis.com.
Get full access to this article
View all access options for this article.
References
1.
AnandI.S., FloreaV.G.Traditional and novel approaches to management of heart failure: successes and failures. Cardiol Clin.2008; 26(1): 59–72.
2.
DaughertyS.L., HoP.M., SpertusJ.A.. Association of early follow-up after acute myocardial infarction with higher rates of medication use. Arch Intern Med.2008; 168(5): 485–491; discussion 492.
3.
DickersonR.N., GarmonW.M., KuhlD.A., MinardG., BrownR.O.Vitamin k-independent warfarin resistance after concurrent administration of warfarin and continuous enteral nutrition. Pharmacotherapy.2008; 28(3): 308–313.
4.
DidomenicoR.J., PerezA., SchumannH.M., FontanaD.R., KondosG.T., SchumockG.T.Impact of treatment guidelines on clinical and economic outcomes of acute decompensated heart failure. Ann Pharmacother.2008; 42(3): 327–333.
5.
FarmakisD., FilippatosG., LainscakM., ParissisJ.T., AnkerS.D., KremastinosD.T.Anticoagulants, antiplatelets, and statins in heart failure. Cardiol Clin.2008; 26(1): 49–58.
6.
MadhwalS., LincoffA.M., RolstonD.D.K.Should patients on long-term warfarin take aspirin for heart disease?Cleve Clin J Med.2008; 75(3): 206–208.
7.
MinichielloT., FogartyP.F.Diagnosis and management of venous thromboembolism. Med Clin North Am.2008; 92(2): 443–465.
8.
RossiniR., AngiolilloD.J., MusumeciG.. Aspirin desensitization in patients undergoing percutaneous coronary interventions with stent implantation. Am J Cardiol.2008; 101(6): 786–789.
9.
SchneeweissS., SeegerJ.D., LandonJ., WalkerA.M.Aprotinin during coronaryartery bypass grafting and risk of death. N Engl J Med.2008; 358(8): 771–783.
10.
ShawA.D., Stafford-SmithM., WhiteW.D.. The effect of aprotinin on outcome after coronary-artery bypass grafting. N Engl J Med.2008; 358(8): 784–793.
11.
DouglasL.C., SandersM.E.Probiotics and prebiotics in dietetics practice. J Am Diet Assoc.2008; 108(3): 510–521.
12.
GooneratneN.S.Complementary and alternative medicine for sleep disturbances in older adults. Clin Geriatr Med.2008; 24(1): 121–138, viii.
13.
HollanderJ.M., MechanickJ.I.Complementary and alternative medicine and the management of the metabolic syndrome. J Am Diet Assoc.2008; 108(3): 495–509.
14.
MillerM.F., BellizziK.M., SufianM., AmbsA.H., GoldsteinM.S., Ballard-BarbashR.Dietary supplement use in individuals living with cancer and other chronic conditions: a population-based study. J Am Diet Assoc.2008; 108(3): 483–494.
15.
RozendaalR.M., KoesB.W., van OschG.J.. Effect of glucosamine sulfate on hip osteoarthritis: a randomized trial. Ann Intern Med.2008; 148(4): 268–277. Summary for patients in: Ann Intern Med. 2008; 148(4): I49.
16.
SoodA., SoodR., BrinkerF.J., MannR., LoehrerL.L., Wahner-RoedlerD.L.Potential for interactions between dietary supplements and prescription medications. Am J Med.2008; 121(3): 207–211.
DonnerT.W., FlammerK.M.Diabetes management in the hospital. Med Clin North Am.2008; 92(2): 407–425.
19.
HornickT., AronD.C.Preventing and managing diabetic complications in elderly patients. Cleve Clin J Med.2008; 75(2): 153–158.
20.
HornickT., AronD.C.Managing diabetes in the elderly: go easy, individualize. Cleve Clin J Med.2008; 75(1): 70–78.
21.
PivonelloR., De MartinoM.C., De LeoM., LombardiG., ColaoA.Cushing's syndrome. Endocrinol Metab Clin North Am.2008; 37(1): 135–149, ix.
22.
ToogoodA.A., StewartP.M.Hypopituitarism: clinical features, diagnosis, and management. Endocrinol Metab Clin North Am.2008; 37(1): 235–261, x.
23.
AsmisT.R., SaltzL.Systemic therapy for colon cancer. Gastroenterol Clin North Am.2008; 37(1): 287–295.
24.
BakerW.F.Jr, BickR.L., FareedJ.Controversies and unresolved issues in antiphospholipid syndrome pathogenesis and management. Hematol Oncol Clin North Am.2008; 22(1): 155–174, viii.
25.
BennettC.L., SilverS.M., DjulbegovicB.. Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia. JAMA.2008; 299(8): 914–924.
26.
BernatskyS., ClarkeA.E., SuissaS.Hematologic malignant neoplasms after drug exposure in rheumatoid arthritis. Arch Intern Med.2008; 168(4): 378–381.
27.
BickR.L., BakerW.F.Treatment options for patients who have antiphospholipid syndromes. Hematol Oncol Clin North Am.2008; 22(1): 145–153, viii.
28.
BurtR.K., LohY., PearceW.. Clinical applications of blood-derived and marrow-derived stem cells for nonmalignant diseases. JAMA.2008; 299(8): 925–936.
29.
CiardielloF., TortoraG.EGFR antagonists in cancer treatment. N Engl J Med.2008; 358(11): 1160–1174.
HeidaryN., NaikH., BurginS.Chemo therapeutic agents and the skin: an update. J Am Acad Dermatol.2008; 58(4): 545–570.
32.
HoppensteadtD.A., WalengaJ.M.The relationship between the antiphospho-lipid syndrome and heparin-induced thrombocytopenia. Hematol Oncol Clin North Am.2008; 22(1): 1–18, v.
33.
KolitzJ.E.Acute leukemias in adults. Dis Mon.2008; 54(4): 226–241.
34.
O'BrienM.M., LacayoN.J.Acute leukemia in children. Dis Mon.2008; 54(4): 202–225.
35.
ShermockK.M., HornE., RiceT.L.Erythropoietic agents for anemia of critical illness. Am J Health Syst Pharm.2008; 65(6): 540–546.
36.
BrattonS.L., Van DukerH., StatlerK.D., PulsipherM.A., McArthurJ., KeenanH.T.Lower hospital mortality and complications after pediatric hematopoietic stem cell transplantation. Crit Care Med.2008; 36(3): 923–927.
37.
HandgretingerR., KurtzbergJ., EgelerR.M.Indications and donor selections for allogeneic stem cell transplantation in children with hematologic malignancies. Pediatr Clin North Am.2008; 55(1): 71–96.
38.
OeffingerK.C., NathanP.C., KremerL.C.Challenges after curative treatment for childhood cancer and long-term follow up of survivors. Pediatr Clin North Am.2008; 55(1): 251–273.
39.
PietersR., CarrollW.L.Biology and treatment of acute lymphoblastic leukemia. Pediatr Clin North Am.2008; 55(1): 1–20.
ShankarA.G.The role of recombinant erythropoietin in childhood cancer. Oncologist.2008; 13(2): 157–166.
42.
CatT.B., CharashW., HebertJ.. Potential influence of antisecretory therapy on the development of Candida-associated intraabdominal infection. Ann Pharmacother.2008; 42(2): 185–191.
43.
GasinkL.B., LautenbachE.Prevention and treatment of health careacquired infections. Med Clin North Am.2008; 92(2): 295–313.
44.
GorwitzR., FridkinS.K., WorkowskiK.A.More challenges in the prevention and management of community-associated, methicillin-resistant Staphylococcus aureus skin disease. Ann Intern Med.2008; 148(4): 310–312.
45.
HarbarthS., FankhauserC., SchrenzelJ.. Universal screening for methicillin-resistant Staphylococcus aureus at hospital admission and nosocomial infection in surgical patients. JAMA.2008; 299(10): 1149–1157.
46.
RehmS.J.Staphylococcus aureus: the new adventures of a legendary pathogen. Cleve Clin J Med.2008; 75(3): 177–192.
47.
RudolphJ.L., SalowM.J., AngeliniM.C., McGlincheyR.E.The anticholinergic risk scale and anticholinergic adverse effects in older persons. Arch Intern Med.2008; 168(5): 508–513.
48.
SafdarN., AbadC.Educational interventions for prevention of healthcare-associated infection: a systematic review. Crit Care Med.2008; 36(3): 933–940.
49.
SharmaS.K., KadhiravanT.Management of the patient with HIV disease. Dis Mon.2008; 54(3): 162–195.
WelkerJ.A., HustonM., McCueJ.D.Antibiotic timing and errors in diagnosing pneumonia. Arch Intern Med.2008; 168(4): 351–356.
52.
BowenM.E., RayW.A., ArbogastP.G., DingH., CooperW.O.Increasing exposure to angiotensin-converting enzyme inhibitors in pregnancy. Am J Obstet Gynecol.2008; 198(3): 291. e1-e5.
53.
ReidyJ., DouglasJ.Vasopressors in obstetrics. Anesthesiol Clin.2008; 26(1): 75–88.
54.
BirnbachD.J., SalasE.Can medical simulation and team training reduce errors in labor and delivery?Anesthesiol Clin.2008; 26(1): 159–168.
55.
CohenA.L., BudnitzD.S., WeidenbachK.N.. National surveillance of emergency department visits for outpatient adverse drug events in children and adolescents. J Pediatr.2008; 152(3): 416–421.
HarjaiK.J., RaizadaA., ShenoyC.. A comparison of contemporary definitions of contrast nephropathy in patients undergoing percutaneous coronary intervention and a proposal for a novel nephropathy grading system. Am J Cardiol.2008; 101(6): 812–819.
58.
KovesdyC.P., AhmadzadehS., AndersonJ.E., Kalantar-ZadehK.Association of activated vitamin D treatment and mortality in chronic kidney disease. Arch Intern Med.2008; 168(4): 397–403.
59.
ChenY., GuoJ.J., LiH., WulsinL., PatelN.C.Risk of cerebrovascular events associated with antidepressant use in patients with depression: a population-based, nested case-control study. Ann Pharmacother.2008; 42(2): 177–184.
60.
LaBreshK.A., ReevesM.J., FrankelM.R., AlbrightD., SchwammL.H.Hospital treatment of patients with ischemic stroke or transient ischemic attack using the “Get With The Guidelines” program. Arch Intern Med.2008; 168(4): 411–417.
61.
QaseemA., SnowV., CrossJ.T.Jr. Current pharmacologic treatment of dementia: a clinical practice guideline from the American College of Physicians and the American Academy of Family Physicians. Ann Intern Med.2008; 148(5): 370–378.
62.
RainaP., SantaguidaP., IsmailaA.. Effectiveness of cholinesterase inhibitors and memantine for treating dementia: evidence review for a clinical practice guideline. Ann Intern Med.2008; 148(5): 379–397.
63.
LiJ.M.Pain management in the hospitalized patient. Med Clin North Am.2008; 92(2): 371–385.
64.
WilseyB.L., FishmanS.M., CrandallM., CasamalhuapaC., BertakisK.D.A qualitative study of the barriers to chronic pain management in the ED. Am J Emerg Med.2008; 26(3): 255–263.
65.
KumarP., WalkerJ.K., HurtK.M., BennettK.M., GrosshansN., FotisM.A.Medication use in the neonatal intensive care unit: current patterns and off-label use of parenteral medications. J Pediatr.2008; 152(3): 412–415.
66.
PurdyJ.B., GafniR.I., ReynoldsJ.C., ZeichnerS., HazraR.Decreased bone mineral density with off-label use of tenofovir in children and adolescents infected with human immunodeficiency virus. J Pediatr.2008; 152(4): 582–584.
67.
TobiasJ.D.Therapeutic applications and uses of inhalational anesthesia in the pediatric intensive care unit. Pediatr Crit Care Med.2008; 9(2): 169–179.
68.
WraithJ.E., Tylki-SzymanskaA., GuffonN.. Safety and efficacy of enzyme replacement therapy with agalsidase beta: an international, open-label study in pediatric patients with Fabry disease. J Pediatr.2008; 152(4): 563–570, 570.e1.
69.
LandauR.Pharmacogenetics and obstetric anesthesia. Anesthesiol Clin.2008; 26(1): 183–195.
70.
McNamaraD.M.Pharmacogenomics for neurohormonal intervention in heart failure. Cardiol Clin.2008; 26(1): 127–135.
71.
ScheunerM.T., SieverdingP., ShekelleP.G.Delivery of genomic medicine for common chronic adult diseases: a systematic review. JAMA.2008; 299(11): 1320–1334.
72.
SchwarzU.I., RitchieM.D., BradfordY.. Genetic determinants of response to warfarin during initial anticoagulation. N Engl J Med.2008; 358(10): 999–1008.
73.
ShurinS.B., NabelE.G.Pharmacogenomics—ready for prime time?N Engl J Med.2008; 358(10): 1061–1063.
74.
BockL.M., DuongM.T., WilliamsJ.S.Enhancing clinical services by using pharmacy students during advanced experiential rotations. Am J Health Syst Pharm.2008;65(6): 566–569.
75.
KhanderiaU., TownsendK.A., EricksonS.R., VlasnikJ., PragerR.L., EagleK.A.Medication adherence following coronary artery bypass graft surgery: assessment of beliefs and attitudes. Ann Pharmacother.2008; 42(2): 192–199.
76.
MillardW.B.Dispatch from the pharmasphere: an industry's fault lines on display. Ann Emerg Med.2008; 51(2): 175–180.
77.
OkaforM.C., ThomasJIII. Presence of innovation adoption-facilitating elements in hospitals, and relationship to implementation of clinical guidelines. Ann Pharmacother.2008; 42(3): 354–360.
78.
SimonianA.I.Medication order communication using fax and document-imaging technologies. Am J Health Syst Pharm.2008; 65(6): 570–573.
79.
van GeffenE.C., van HultenR., EgbertsA.C., HeerdinkE.R.Characteristics and reasons associated with nonacceptance of selective serotonin-reuptake inhibitor treatment. Ann Pharmacother.2008; 42(2): 218–225.
80.
WymoreE.S., CasanovaT.J., BroekemeierR.L., MartinJ.K.Jr. Clinical pharmacist's daily role in the emergency department of a community hospital. Am J Health Syst Pharm.2008; 65(5): 395–396, 398-399.
BabuK.M., ChurchR.J., LewanderW.Energy drinks: the new eye-opener for adolescents. Clin Ped Emerg Med.2008; 9(1): 35–42.
83.
BaileyB.To decontaminate or not to decontaminate? The balance between potential risks and foreseeable benefits. Clin Ped Emerg Med.2008; 9(1): 17–23.
84.
LiebeltE.L.An update on antidepressant toxicity: an evolution of unique toxicities to master. Clin Ped Emerg Med.2008; 9(1): 24–34.
85.
ScalzoA.J., Lehman-HuskampK.L., SinksG.A., KeenanW.J.Disaster preparedness and toxic exposures in children. Clin Ped Emerg Med.2008; 9(1): 47–60.
86.
BunnapradistS., NeriL., WongW.. Incidence and risk factors for diarrhea following kidney transplantation and association with graft loss and mortality. Am J Kidney Dis.2008; 51(3): 478–486.
87.
HoehnK.S., FraderJ.E.Approaching parents for organ donation: who and when?Pediatr Crit Care Med.2008; 9(2): 234–235.
88.
TruogR.D.Consent for organ donation—balancing conflicting ethical obligations. N Engl J Med.2008; 358(12): 1209–1211.
89.
AbrahamianF.M., MoranG.J., TalanD.A.Urinary tract infections in the emergency department. Infect Dis Clin North Am.2008; 22(1): 73–87.
90.
AbrahamianF.M., TalanD.A., MoranG.J.Management of skin and soft-tissue infections in the emergency department. Infect Dis Clin North Am.2008; 22(1): 89–116.
91.
CoxE.C., ReedS.D., GovertJ.A.. Economic evaluation of propofol and lorazepam for critically ill patients undergoing mechanical ventilation. Crit Care Med.2008; 36(3): 706–714.
92.
FitchM.T., AbrahamianF.M., MoranG.J., TalanD.A.Emergency department management of meningitis and encephalitis. Infect Dis Clin North Am.2008; 22(1): 33–52.
93.
InabaK., TeixeiraP.G., DavidJ.S.. Beta-blockers in isolated blunt head injury. J Am Coll Surg.2008;206(3): 432–438.
94.
MoranG.J., TalanD.A., AbrahamianF.M.Antimicrobial prophylaxis for wounds and procedures in the emergency department. Infect Dis Clin North Am.2008;22(1): 117–143.
MoranG.J., TalanD.A., AbrahamianF.M.Diagnosis and management of pneumonia in the emergency department. Infect Dis Clin North Am.2008; 22(1): 53–72.
97.
RussellJ.A., WalleyK.R., SingerJ.. Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med.2008; 358(9): 877–887.
98.
SawyerE., MauroL.S., OhlingerM.J.Amantadine enhancement of arousal and cognition after traumatic brain injury. Ann Pharmacother.2008; 42(2): 247–252.
99.
TalanD.A., MoranG.J., AbrahamianF.M.Severe sepsis and septic shock in the emergency department. Infect Dis Clin North Am.2008; 22(1): 1–31.
100.
TapsonV.F.Acute pulmonary embolism. N Engl J Med.2008; 358(10): 1037–1052.
101.
TruogR.D., CampbellM.L., CurtisJ.R.. Recommendations for end-of-life care in the intensive care unit: a consensus statement by the American Academy of Critical Care Medicine. Crit Care Med.2008; 36(3): 953–963.
102.
BeatyA.D., LiebermanP.L., SlavinR.G.Seafood allergy and radiocontrast media: are physicians propagating a myth?Am J Med.2008; 121(2): 158.e1-e4.
103.
BergeK.H., MorseR.M.Protocol-driven treatment of alcohol withdrawal in a general hospital: when theory meets practice. Mayo Clin Proc.2008; 83(3): 270–271.
104.
DudzinskiD.M., KesselheimA.S.Scientific and legal viability of follow-on protein drugs. N Engl J Med.2008; 358(8): 843–849.
105.
FernandezH.M., CallahanK.E., LikourezosA., LeipzigR.M.House staff member awareness of older inpatients' risks for hazards of hospitalization. Arch Intern Med.2008; 168(4): 390–396.
106.
FlahertyJ.H.Insomnia among hospitalized older persons. Clin Geriatr Med.2008 Feb; 24(1): 51–67, vi.
107.
FroschD.L., BhatnagarV., TallyS., HamoriC.J., KaplanR.M.Internet patient decision support: a randomized controlled trial comparing alternative approaches for men considering prostate cancer screening. Arch Intern Med.2008; 168(4): 363–369.
108.
HeckselK.A., BostwickJ.M., JaegerT.M., ChaS.S.Inappropriate use of symptom-triggered therapy for alcohol withdrawal in the general hospital. Mayo Clin Proc.2008; 83(3): 274–279.
109.
HeissG., WallaceR., AndersonG.L.. Health risks and benefits 3 years after stopping randomized treatment with estrogen and progestin. JAMA.2008; 299(9): 1036–1045.
110.
JagsiR., WeinsteinD.F., ShapiroJ., KitchB.T., DorerD., WeissmanJ.S.The Accreditation Council for Graduate Medical Education's limits on residents' work hours and patient safety. A study of resident experiences and perceptions before and after hours reductions. Arch Intern Med.2008; 168(5): 493–500.
111.
MakkarR., ShenB.What are the caveats to using sodium phosphate agents for bowel preparation. Cleve Clin J Med.2008; 75(3): 173–176.
112.
NahataM.C.Tips for writing and publishing an article. Ann Pharmacother.2008; 42(2): 273–277.
113.
PodrazikP.M., WhelanC.T.Acute hospital care for the elderly patient: its impact on clinical and hospital systems of care. Med Clin North Am.2008; 92(2): 387–406.
114.
TariqS.H., PulisettyS.Pharmacotherapy for insomnia. Clin Geriatr Med.2008; 24(1): 93–105, vii.
115.
WaberR.L., ShivB., CarmonZ., ArielyD.Commercial features of placebo and therapeutic efficacy. JAMA.2008; 299(9): 1016–1017.
